366 related articles for article (PubMed ID: 7753829)
21. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms.
Amos-Landgraf JM; Irving AA; Hartman C; Hunter A; Laube B; Chen X; Clipson L; Newton MA; Dove WF
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2060-5. PubMed ID: 22308460
[TBL] [Abstract][Full Text] [Related]
22. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes.
Takaku K; Oshima M; Miyoshi H; Matsui M; Seldin MF; Taketo MM
Cell; 1998 Mar; 92(5):645-56. PubMed ID: 9506519
[TBL] [Abstract][Full Text] [Related]
23. Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice.
Mohammad HP; Zhang W; Prevas HS; Leadem BR; Zhang M; Herman JG; Hooker CM; Watkins DN; Karim B; Huso DL; Baylin SB
Oncogene; 2011 Jun; 30(23):2659-69. PubMed ID: 21297660
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
[TBL] [Abstract][Full Text] [Related]
25. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis.
Smits R; Kartheuser A; Jagmohan-Changur S; Leblanc V; Breukel C; de Vries A; van Kranen H; van Krieken JH; Williamson S; Edelmann W; Kucherlapati R; KhanPM ; Fodde R
Carcinogenesis; 1997 Feb; 18(2):321-7. PubMed ID: 9054624
[TBL] [Abstract][Full Text] [Related]
26. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
Lee J; Hargest R; Wasan H; Phillips RK
Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
[TBL] [Abstract][Full Text] [Related]
27. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
28. Alpha-catenin is essential in intestinal adenoma formation.
Shibata H; Takano H; Ito M; Shioya H; Hirota M; Matsumoto H; Kakudo Y; Ishioka C; Akiyama T; Kanegae Y; Saito I; Noda T
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18199-204. PubMed ID: 17989230
[TBL] [Abstract][Full Text] [Related]
29. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
[TBL] [Abstract][Full Text] [Related]
31. E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice.
Smits R; Ruiz P; Diaz-Cano S; Luz A; Jagmohan-Changur S; Breukel C; Birchmeier C; Birchmeier W; Fodde R
Gastroenterology; 2000 Oct; 119(4):1045-53. PubMed ID: 11040191
[TBL] [Abstract][Full Text] [Related]
32. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
Clarke AR; Cummings MC; Harrison DJ
Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622
[TBL] [Abstract][Full Text] [Related]
33. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
[TBL] [Abstract][Full Text] [Related]
34. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
[TBL] [Abstract][Full Text] [Related]
35. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
[TBL] [Abstract][Full Text] [Related]
36. Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.
Ignatenko NA; Holubec H; Besselsen DG; Blohm-Mangone KA; Padilla-Torres JL; Nagle RB; de Alboránç IM; Guillen-R JM; Gerner EW
Cancer Biol Ther; 2006 Dec; 5(12):1658-64. PubMed ID: 17106247
[TBL] [Abstract][Full Text] [Related]
37. Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
Ahn B; Ohshima H
Cancer Res; 2001 Dec; 61(23):8357-60. PubMed ID: 11731407
[TBL] [Abstract][Full Text] [Related]
38. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
Silverman KA; Koratkar R; Siracusa LD; Buchberg AM
Genome Res; 2002 Jan; 12(1):88-97. PubMed ID: 11779834
[TBL] [Abstract][Full Text] [Related]
39. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism.
Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB
J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668
[TBL] [Abstract][Full Text] [Related]
40. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.
Roberts RB; Min L; Washington MK; Olsen SJ; Settle SH; Coffey RJ; Threadgill DW
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1521-6. PubMed ID: 11818567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
